Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Erik Oleson

Concepts (181)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dopamine
25
2025
285
6.580
Why?
Nucleus Accumbens
21
2020
126
5.350
Why?
Endocannabinoids
10
2021
39
2.380
Why?
Avoidance Learning
6
2020
67
2.380
Why?
Reward
12
2021
240
2.360
Why?
Behavior, Animal
12
2018
484
2.230
Why?
Cocaine
12
2013
148
1.990
Why?
Heroin
2
2020
30
1.380
Why?
Cannabinoids
3
2021
129
1.330
Why?
Benzoxazines
3
2020
29
1.320
Why?
Cannabinoid Receptor Agonists
5
2021
36
1.280
Why?
Naphthalenes
3
2020
56
1.280
Why?
Motivation
6
2020
546
1.250
Why?
Morpholines
3
2020
122
1.250
Why?
Dopamine Antagonists
2
2020
21
1.060
Why?
Rats
24
2025
5165
1.050
Why?
Self Administration
8
2013
122
1.030
Why?
Analgesics, Opioid
2
2020
887
0.810
Why?
Arachidonic Acids
4
2020
54
0.780
Why?
Rats, Long-Evans
7
2025
119
0.760
Why?
Economics, Behavioral
2
2018
9
0.760
Why?
Substance Withdrawal Syndrome
3
2021
169
0.740
Why?
Biological Psychiatry
1
2021
2
0.730
Why?
Neuropharmacology
1
2021
6
0.730
Why?
Psychopharmacology
1
2021
9
0.720
Why?
Cocaine-Related Disorders
6
2012
108
0.700
Why?
Drug Tolerance
1
2020
83
0.690
Why?
Dopamine Uptake Inhibitors
2
2012
55
0.680
Why?
Central Nervous System Stimulants
2
2012
153
0.660
Why?
Animals
37
2025
34479
0.640
Why?
Conditioning, Operant
6
2013
102
0.640
Why?
Diazepam
2
2018
27
0.610
Why?
Fear
4
2025
325
0.570
Why?
Dose-Response Relationship, Drug
8
2020
1936
0.560
Why?
Corpus Striatum
3
2025
155
0.540
Why?
Buprenorphine
1
2020
161
0.540
Why?
Receptor, Cannabinoid, CB1
3
2013
39
0.510
Why?
Marijuana Abuse
3
2021
229
0.490
Why?
Neurochemistry
1
2014
6
0.480
Why?
Reinforcement Schedule
6
2013
30
0.470
Why?
Ventral Tegmental Area
2
2013
50
0.470
Why?
Escape Reaction
1
2014
61
0.470
Why?
Rats, Sprague-Dawley
12
2018
2239
0.460
Why?
Consummatory Behavior
2
2010
5
0.440
Why?
Biological Clocks
1
2013
40
0.430
Why?
Neurotransmitter Agents
1
2013
78
0.420
Why?
Punishment
1
2012
20
0.400
Why?
Dronabinol
3
2021
166
0.400
Why?
Benztropine
1
2012
2
0.400
Why?
Dopaminergic Neurons
4
2025
57
0.390
Why?
Extinction, Psychological
3
2025
86
0.390
Why?
Histamine H1 Antagonists
1
2012
29
0.390
Why?
Cannabinoid Receptor Modulators
1
2012
7
0.390
Why?
Glycerides
3
2020
16
0.380
Why?
Piperidines
2
2013
190
0.370
Why?
GABA-B Receptor Agonists
1
2010
4
0.360
Why?
Appetitive Behavior
1
2010
8
0.360
Why?
Brain
4
2021
2620
0.350
Why?
Analgesics
2
2020
163
0.310
Why?
Male
28
2025
62857
0.310
Why?
Motor Activity
3
2013
668
0.310
Why?
Cues
5
2018
321
0.250
Why?
Substantia Nigra
1
2025
56
0.240
Why?
Electrochemical Techniques
2
2018
48
0.220
Why?
Models, Animal
2
2018
366
0.220
Why?
Substance-Related Disorders
1
2012
1013
0.210
Why?
Carrier Proteins
4
2006
732
0.190
Why?
Time Factors
5
2017
6482
0.180
Why?
Crime Victims
1
2022
111
0.170
Why?
Drug Administration Schedule
2
2020
751
0.170
Why?
Receptors, Opioid, mu
1
2020
56
0.170
Why?
Administration, Intravenous
1
2020
135
0.170
Why?
Optogenetics
2
2018
112
0.170
Why?
Sex Offenses
1
2022
178
0.160
Why?
Mice, Inbred C57BL
6
2013
5272
0.160
Why?
Drug Combinations
1
2020
323
0.160
Why?
Mice
10
2021
16602
0.160
Why?
N-Methyl-3,4-methylenedioxyamphetamine
1
2018
10
0.160
Why?
Serotonin Agents
1
2018
8
0.160
Why?
GABA-A Receptor Agonists
1
2018
9
0.160
Why?
GABA-A Receptor Antagonists
1
2018
16
0.160
Why?
Sexual and Gender Minorities
1
2022
193
0.150
Why?
Memory Consolidation
1
2018
11
0.150
Why?
Pain Measurement
1
2020
487
0.150
Why?
Flumazenil
1
2017
6
0.150
Why?
Receptors, GABA-A
1
2018
97
0.140
Why?
Central Nervous System Depressants
2
2007
82
0.130
Why?
Synaptic Transmission
2
2021
258
0.120
Why?
Neurons
2
2014
1448
0.120
Why?
Geriatrics
1
2015
80
0.120
Why?
Clinical Clerkship
1
2015
95
0.110
Why?
Polyunsaturated Alkamides
1
2013
6
0.110
Why?
Exploratory Behavior
2
2012
86
0.110
Why?
Age Factors
1
2020
3103
0.100
Why?
Neuronal Plasticity
2
2006
263
0.100
Why?
Education, Medical, Undergraduate
1
2015
176
0.100
Why?
Drug-Seeking Behavior
1
2013
22
0.100
Why?
Task Performance and Analysis
1
2013
173
0.100
Why?
Drug and Narcotic Control
1
2012
28
0.100
Why?
Mental Disorders
1
2021
1027
0.100
Why?
Impulsive Behavior
1
2013
128
0.100
Why?
Spatial Behavior
1
2012
24
0.100
Why?
Ethanol
2
2007
584
0.090
Why?
Psychomotor Agitation
1
2012
64
0.090
Why?
Action Potentials
1
2014
468
0.090
Why?
Behavior, Addictive
1
2012
81
0.090
Why?
Baclofen
1
2010
12
0.090
Why?
Forecasting
1
2012
358
0.090
Why?
Haloperidol
1
2010
32
0.090
Why?
Fluoxetine
1
2010
52
0.090
Why?
Humans
9
2022
128417
0.080
Why?
Electroencephalography
1
2012
396
0.080
Why?
Mesencephalon
1
2009
66
0.080
Why?
Infusions, Intravenous
1
2010
385
0.080
Why?
Limbic System
1
2009
46
0.080
Why?
Neuropeptides
1
2009
71
0.080
Why?
Nerve Net
1
2012
256
0.080
Why?
Databases, Factual
1
2014
1269
0.080
Why?
Neuropsychological Tests
1
2013
1002
0.080
Why?
Dopamine Plasma Membrane Transport Proteins
1
2008
47
0.080
Why?
Kinetics
1
2012
1615
0.080
Why?
Injections, Intravenous
1
2008
190
0.070
Why?
Commerce
1
2008
69
0.070
Why?
Analysis of Variance
1
2010
1269
0.070
Why?
Models, Theoretical
1
2010
542
0.070
Why?
Intracellular Signaling Peptides and Proteins
1
2009
431
0.070
Why?
Glutamic Acid
2
2006
230
0.070
Why?
Signal Transduction
3
2021
4826
0.060
Why?
Homer Scaffolding Proteins
4
2006
5
0.060
Why?
Anesthetics, Local
1
2006
75
0.060
Why?
Estrous Cycle
1
2025
21
0.060
Why?
Maze Learning
1
2005
93
0.060
Why?
Models, Biological
2
2012
1691
0.060
Why?
Frontal Lobe
1
2005
153
0.060
Why?
Psychomotor Performance
1
2005
311
0.050
Why?
Prefrontal Cortex
1
2005
299
0.050
Why?
Memory
2
2018
232
0.050
Why?
Algorithms
1
2008
1618
0.040
Why?
Sex Characteristics
1
2025
721
0.040
Why?
GABA Modulators
1
2018
9
0.040
Why?
Survivors
1
2022
463
0.040
Why?
Organ Culture Techniques
1
2018
142
0.040
Why?
Microdialysis
2
2009
51
0.040
Why?
Gene Expression Regulation
1
2006
2505
0.030
Why?
Mice, Knockout
3
2005
2755
0.030
Why?
Protein Isoforms
2
2006
378
0.030
Why?
Goals
1
2015
160
0.030
Why?
Cannabinoid Receptor Antagonists
1
2013
1
0.030
Why?
Gene Deletion
2
2005
370
0.030
Why?
Schizophrenia
2
2005
428
0.020
Why?
Orexin Receptors
1
2009
3
0.020
Why?
Orexins
1
2009
5
0.020
Why?
Pyrazoles
1
2013
404
0.020
Why?
Receptors, Neuropeptide
1
2009
12
0.020
Why?
Naphthyridines
1
2009
15
0.020
Why?
Benzoxazoles
1
2009
19
0.020
Why?
Electrochemistry
1
2009
80
0.020
Why?
Urea
1
2009
75
0.020
Why?
Random Allocation
1
2009
343
0.020
Why?
Receptors, G-Protein-Coupled
1
2009
203
0.020
Why?
Caudate Nucleus
1
2007
20
0.020
Why?
Putamen
1
2007
22
0.020
Why?
Volatilization
1
2007
52
0.020
Why?
Receptors, Dopamine D2
1
2007
89
0.020
Why?
Female
4
2025
68153
0.020
Why?
Cannabis
1
2012
429
0.020
Why?
Administration, Inhalation
1
2007
661
0.020
Why?
Excitatory Amino Acid Antagonists
1
2005
91
0.020
Why?
Reflex
1
2005
68
0.010
Why?
Down-Regulation
1
2007
631
0.010
Why?
Drug Synergism
1
2005
359
0.010
Why?
Chromatography, High Pressure Liquid
1
2006
475
0.010
Why?
Neural Inhibition
1
2005
151
0.010
Why?
Receptors, N-Methyl-D-Aspartate
1
2005
200
0.010
Why?
Piperazines
1
2005
336
0.010
Why?
Mice, Inbred BALB C
1
2005
1228
0.010
Why?
Recombinant Proteins
1
2006
1281
0.010
Why?
Oxidative Stress
1
2005
1176
0.010
Why?
Alcohol Drinking
1
2005
752
0.010
Why?
Polymorphism, Single Nucleotide
1
2005
2062
0.010
Why?
Phenotype
1
2005
3044
0.010
Why?
Oleson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)